IMMUNOGENIC COMPOSITION FOR THE PREVENTION OF MARINE TENACIBACULOSIS CAUSED BY TENACIBACULUM MARITIMUM AND TENACIBACULUM SOLEAE IN FISH, PRODUCTION METHOD AND USE

Patent number:

ES2939719

Galicia.svg
No items found.

The invention discloses an immunogenic composition for the prevention of marine tenacibaculosis, a disease that affects marine and anadromous fish with great commercial value, comprising the strains Tenacibaculum maritimum CECT 30394 and Tenacibaculum soleae CECT 30393. The invention further includes its production method and the use thereof against said disease.

Countries:
Spain
Regions:
Galicia
Centers:
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 5 – technology validated in relevant environment (industrially relevant environment in the case of key enabling technologies)
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

Administration by immersion of the fish in the composition diluted 1:1000 in seawater (2 baths of 2 minutes, separated by an interval of four weeks) or by injection (dose of 0.1 mL/fish) confers to the fish high levels of protection (RPS=70-100%) against marine tenacibaculosis caused by both pathogenic species This developed immunogenic composition is an advantage over the described experimental monovalent vaccines or the commercial ICTHIOVAC-TM vaccine, since it allows: 1) Improve antigenic coverage by including strains of the species T. marítimum and T. soleae, the main causes of tenacibaculosis worldwide. 2) Protect against tenacibaculosis caused by T. maritimumyT. soleaea fish species of great commercial interest.

Comments

Other related patents

Chemicals
Health
New & Sustainable Materials

SELF-IMMOLATIVE MICELLE, METHODS AND USES THEREOF

Countries
Portugal
Know more
Health

NEUROSTIMULATION SYSTEM

Countries
Spain
Know more
Health

MEDICAL USES OF APOLIPOPROTEIN A AND ACTIVATORS THEREOF

Countries
Spain
Know more
Get back to patents directory